Tue, Mar 3, 2015, 5:46 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

OXiGENE, Inc. Message Board

  • jh89169 jh89169 Nov 15, 2013 8:56 PM Flag

    Just A Matter Of Time....

    before Oxgene announce a partnership. Be patient and your patience will evantually be handsomely rewarded.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • This deal was made in 2007 for a similar drug. Maybe those days, market was crazy, but a partnership like this for a fraction of this amount will double share price.

      THURSDAY, APRIL 19, 2007
      Antisoma Licenses AS1404: The Sequel
      Only occasionally are sequels better than the original. The Godfather Part II. The Empire Strikes Back, of course. Add to those classics UK biotech Antisoma's second go-around with its vascular disrupting agent AS1404, which today it partnered with Novartis in a world-wide deal worth up to $890 million (including $100 million in near-term payments) plus royalties. Novartis will conduct and fund all development in all indications going forward.

1.73-0.04(-2.26%)Mar 3 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.